Identifying PBM Audit Red Flags
In recent years, PBM audits have become more comprehensive, often going beyond traditional areas like billing to scrutinize state licensing, copay handling, and even staff credentialing. For independent pharmacies, these audits can pose a major challenge, with minor operational oversights potentially leading to significant issues—payment recoupments, contract suspension, or, in extreme cases, network termination. The best way to minimize these risks is to understand exactly what PBMs are watching for and why.
This guide is designed as a practical “watchlist” of the top audit triggers PBMs monitor most frequently. By understanding why these areas attract scrutiny, pharmacies can implement proactive steps to manage each one before it raises any questions. We’ll cover everything from high-cost medication trends and controlled substance inventory to overlapping regulatory requirements and unusual patient demographics. For each trigger, you’ll find straightforward steps you can take to stay compliant, transparent, and audit-ready.
The goal? To help your pharmacy build a strong, audit-resistant operation that meets both PBM and regulatory standards—while keeping the focus on patient care. Let’s get into the most common triggers PBMs look for and how you can stay one step ahead.
Patterns in High-Cost Medications
PBMs keep a close watch on high-cost drugs, as these prescriptions carry significant financial implications and can sometimes signal potential issues like overuse or lack of clinical justification. Even when prescriptions are legitimate, frequent dispensing of high-cost medications without thorough documentation can raise PBM concerns.
Why PBMs Flag High-Cost Medications
High-cost drugs are flagged because they have an outsized impact on healthcare spending. Patterns of frequent or high-volume claims for these drugs may lead PBMs to question if the prescriptions are clinically necessary or if they align with best practices. PBMs are also increasingly asking for proof that copayments for these drugs are collected directly by the pharmacy, especially if third-party payment systems are used.
Strategies for Managing and Documenting High-Cost Drugs
- Customize Documentation for High-Cost Prescriptions
- High-cost medications require detailed, case-specific documentation. Go beyond the basics by including patient diagnosis, prescriber notes, and any prior authorizations to demonstrate necessity. This is especially critical for prescriptions that fall outside standard treatment protocols. PBMs are less likely to flag well-documented prescriptions, so thoroughness here can prevent a lot of issues.
- Maintain a High-Cost Medication Log and Review Regularly
- Keep a running log of high-cost prescriptions, detailing information like diagnosis, prescriber, and treatment duration. Review this log monthly to spot any patterns or trends that PBMs might question, such as higher-than-average quantities or frequent refills. By proactively reviewing these logs, you’re better prepared to respond to PBM inquiries with documented explanations.
- Ensure Accurate Copay Documentation
- PBMs are now more likely to request proof that copays for high-cost drugs are collected directly by the pharmacy. If you use a third-party system, make sure it has a record of the payment going directly into your account. Proper copay documentation is especially critical for high-cost drugs, as any gaps in this area could lead PBMs to scrutinize your billing practices.
- Stay Alert to PBM and Regulatory Updates
- With PBMs tightening standards around high-cost drug dispensing, stay informed about changes to PBM guidelines and state/federal regulations. This helps you adjust documentation and billing practices proactively, ensuring your pharmacy remains compliant without needing to scramble when an audit is on the horizon.
Frequent Adjustments and Overrides
PBMs often see frequent adjustments and overrides as potential red flags. While overrides are sometimes necessary, a high rate of these adjustments without clear documentation can signal billing inconsistencies. PBMs are increasingly scrutinizing these areas to ensure compliance with billing protocols, especially regarding pharmacy involvement in prior authorizations.
Why PBMs Monitor Overrides
Frequent overrides can suggest attempts to bypass billing protocols or mask errors, even if unintentional. PBMs want to see that each override is justified and documented, especially as the focus on cost control intensifies. Additionally, with new restrictions, PBMs now expect pharmacies to avoid initiating or managing prior authorizations outside of their specified guidelines, as this area is commonly associated with flagged discrepancies.
Effective Strategies for Managing Overrides and Adjustments
- Limit Overrides to Clearly Documented Medical Necessity
- Overrides should only be applied when they’re genuinely necessary. For each one, record the specific reason and include notes that explain the medical necessity, especially if it falls outside standard practice. Make sure each override has complete, up-to-date documentation to satisfy PBM expectations in case of an audit.
- Implement Regular Reviews of Override Patterns
- Conduct a monthly review of override patterns to identify any frequent adjustments that could appear unusual. For example, if certain medications or conditions often require overrides, assess why this is happening. Addressing these trends early shows PBMs that your pharmacy is actively monitoring and justifying these cases.
- Establish a Consistent Override Documentation Process
- Create a standard process for documenting each override, including a checklist to ensure all necessary information is captured, such as prescriber approval and the clinical reason. This consistency reduces errors and helps ensure that every override is justifiable if reviewed by PBMs.
Billing Patterns in High-Volume or Specialty Drugs
Billing for high-volume or specialty drugs can feel like walking a tightrope. PBMs watch these drugs closely because they’re expensive, and any unusual billing patterns—whether due to quantity, frequency, or specific coding issues—can trigger an audit. If your pharmacy dispenses a significant amount of high-volume or specialty drugs, getting a handle on these billing details is key to keeping PBMs off your back.
Why PBMs Flag Specialty and High-Volume Drug Billing
PBMs see these prescriptions as high risk because they’re costly and susceptible to misuse or overutilization. Even honest mistakes in billing codes, patient eligibility checks, or prescription verification can make PBMs question the legitimacy of these claims. They’re looking for accuracy in every step of the process, from patient eligibility to the specific billing codes used.
How to Keep Billing Smooth and Above Board
- Triple-Check Your Billing Codes and Eligibility
- Specialty drugs come with their own set of codes and requirements, and even minor mistakes here can lead to PBM inquiries. Make sure every claim is billed with the correct codes, and verify patient eligibility before submission. Set up reminders or alerts in your system if needed—this small step can prevent a lot of headaches.
- Document Delivery and Patient Verification for Mailed Prescriptions
- For pharmacies that mail out prescriptions, PBMs now often want proof of delivery and patient verification. Keep thorough records of every delivery, including patient confirmations. This way, if PBMs ask, you’ve got the documentation on hand to show that each prescription reached the right person.
- Ensure Prior Authorization Compliance
- Ensure your team understands and follows PBM guidelines on prior authorizations. Some PBMs restrict pharmacy involvement in initiating or completing prior authorizations, so make sure your pharmacy only engages within approved boundaries. This step can prevent inadvertent red flags that may result from handling prior authorizations beyond PBM limitations.
- Spot Patterns Early—Review Monthly
- Take time each month to review your high-volume drug claims. Are there any unusual spikes in specific drugs or billing issues cropping up more often? This quick review helps you catch potential problems early, giving you time to fix them and adjust documentation if needed.
Managing high-volume and specialty drug billing isn’t just about preventing audits; it’s about keeping a well-organized, transparent process that stands up under PBM scrutiny. By taking a proactive approach with codes, eligibility checks, and consistent training, you’ll create a system that PBMs can’t easily question.
Unusual Patient Demographics or Prescribing Sources
If your pharmacy sees a lot of prescriptions from one provider or serves a unique patient demographic, PBMs might raise an eyebrow. They’re looking for anything that falls outside the “norm”—high volumes of scripts from a single source, unusual age distributions, or specific prescribing patterns. Even if these trends make perfect sense for your pharmacy, it’s essential to be prepared with solid documentation.
Why PBMs Look at Demographics and Prescriber Patterns
PBMs often flag outliers because, from their perspective, they can be indicators of potential fraud or abuse. For example, a large number of prescriptions from one provider might raise suspicions about over-prescribing or unusual provider relationships. Similarly, seeing a high percentage of patients in specific age groups or regions can make PBMs want to verify the legitimacy of these patterns.
Here’s how to keep these patterns well-documented and ready to explain:
- Document the Reason for Any “Unusual” Trends
- If you’re working with a high-volume prescriber or seeing unique demographic patterns (e.g., a concentration of elderly patients), have clear documentation that explains why. If it’s due to a referral relationship or your pharmacy’s location, add notes that explain this context. Having a straightforward reason ready helps quickly clear up questions if PBMs come knocking.
- Track Prescriber Volume and Patient Demographics
- Set up a simple tracking system for prescriber volume and demographic information. This way, you can easily review trends, and it’ll be right at your fingertips if PBMs ask for an explanation. Keeping tabs on this data can also help you spot any changes in prescribing patterns, which might need extra attention.
- Ensure Multi-State Licensing Compliance for Out-of-State Patients
- Serving out-of-state patients, like seasonal residents or “snowbirds,” can be perfectly legitimate, but it also comes with additional PBM scrutiny. Ensure you’re compliant with licensing requirements in each state where you serve patients, as PBMs increasingly check multi-state compliance. It’s a step that protects your pharmacy from unexpected audit triggers.
- Set Alerts for High-Volume Prescribers
- If you have certain prescribers who frequently refer patients to you, consider adding alerts in your system. This way, you’re aware of any sudden increases and can keep documentation updated. It’s a simple step, but one that ensures you stay informed and ready if PBMs ask about high-volume sources.
The bottom line? When it comes to unusual demographics or prescribing sources, staying transparent and organized is your best defense. By tracking and documenting these trends consistently, you can address any PBM concerns with clarity and confidence.
Inventory Discrepancies in Controlled Substances
Controlled substances are under constant scrutiny, and even small inventory discrepancies can raise major red flags with PBMs and regulatory bodies. Given the high risk of diversion, PBMs want to see airtight handling and record-keeping for these medications. Even minor mismatches in inventory counts or documentation can lead to serious questions about compliance. In addition to PBMs, the DEA also conducts audits and inspections around controlled substances, so this area has broader implications beyond PBM audits.
Why PBMs Watch Controlled Substance Inventory
Controlled substances are at a higher risk for diversion, so PBMs monitor these medications closely to ensure that pharmacies are handling them responsibly. Any discrepancies—whether from miscounts, data entry errors, or stock mismatches—can look suspicious and suggest either sloppy record-keeping or, in the worst case, intentional diversion.
How to Keep Controlled Substance Inventory Tight and Transparent
- Conduct Regular Internal Audits
- Don’t wait for a PBM audit to check your controlled substance inventory. Make internal audits a regular practice—whether that’s monthly or weekly, depending on your volume. These checks help you catch issues early, correct errors, and build a record of your proactive approach to compliance. It’s extra work, but it pays off by showing PBMs you’re serious about accurate inventory.
- Maintain a Detailed Discrepancy Log
- If any discrepancies come up, don’t just fix them—document them. Keep a log that notes every variance and explains how it was resolved. Whether it’s a small counting error or a misplacement, logging these discrepancies shows that your pharmacy tracks controlled substances with care and handles any issues promptly. This is invaluable if PBMs ever question your records.
- Restrict and Document Access
- Controlled substances shouldn’t be accessible to just anyone in the pharmacy. Limit access to authorized personnel only, and make sure each staff member understands the importance of inventory security. PBMs are increasingly focused on access control, so keep a clear record of who has access to controlled substances and when. This simple step protects your pharmacy and reassures PBMs about your internal controls.
- Consider Automated Tracking Systems
- If budget allows, consider using an automated tracking system for controlled substances. These systems not only minimize human error but also provide detailed audit trails that PBMs value. Automation can make a huge difference in accuracy and saves time on inventory counts and record-keeping.
Managing controlled substance inventory with careful audits, limited access, and a transparent discrepancy log isn’t just about staying compliant—it’s about protecting your pharmacy from risk. With a consistent system in place, you show PBMs and regulators that your handling of controlled substances is thorough and reliable, leaving little room for doubt.
Compliance Check: Regulatory Overlaps with PBM Audits
PBMs are increasingly focused on areas that overlap with state and federal regulatory standards. This means that PBM audits may touch on compliance issues traditionally outside their scope, like patient data handling, staff training, or even specific licensing requirements. For many pharmacies, it’s easy to overlook these overlaps, but they’re becoming a more common trigger for PBM scrutiny.
Why PBMs Monitor Regulatory Compliance
PBMs are leveraging these regulatory overlaps as a way to ensure that pharmacies in their network meet broader healthcare standards. From PBM’s perspective, these checks contribute to network integrity. For pharmacies, though, it can mean added layers of compliance to manage, as gaps in regulatory areas may quickly raise PBM concerns.
Strategies for Managing Regulatory Overlaps and Staying Compliant
- Develop a Master Checklist for Compliance
- Creating a master checklist that covers both PBM guidelines and broader regulatory standards is invaluable. Include all relevant compliance areas—like patient data protection, controlled substance protocols, and staff credentialing requirements. This checklist is your go-to for staying organized, and regular updates keep it relevant as standards evolve.
- Set Up Quarterly Internal Reviews
- Conduct short but consistent internal reviews focused on these overlapping compliance areas. These reviews don’t have to be exhaustive but should ensure that key regulatory requirements are being met and documented. This proactive check-in allows you to catch potential issues early and make quick adjustments.
- Keep Your Credentialing Information Up-to-Date
- Make sure that all credentialing information with PBMs—such as hours of operation, business activities, and state licensing—is current. Credentialing discrepancies, like outdated hours or unlisted services, can flag your pharmacy for an audit, so regular updates here are essential.
- Stay Alert for Changes in PBM and Regulatory Standards
- Standards are continually shifting, so staying informed about PBM updates as well as state and federal requirements is crucial. Quick adjustments to new guidelines keep your pharmacy in compliance and ready for any audit, avoiding the need for last-minute changes if a PBM raises concerns.
By aligning PBM compliance with regulatory requirements, you’re not only prepared for audits but also building a resilient, compliant operation. These overlaps might feel like extra work, but keeping ahead of them means you’ll meet the expectations of both PBMs and regulators without scrambling when audits happen.
Conclusion: Building a Trigger-Resistant Operation
PBM audits can feel intimidating, but understanding and managing audit triggers can help you stay in control. Rather than viewing compliance as just another burden, think of it as a foundation for running a smooth, trusted pharmacy operation. By addressing potential red flags like high-cost medications, frequent overrides, and controlled substance inventory, you can create a system that naturally aligns with PBM expectations.
Here’s a quick recap to keep your pharmacy “trigger-resistant”:
- Use a Red Flag Checklist
- Create a quick-reference checklist based on the triggers discussed here. Regularly review your documentation, billing, and inventory practices to ensure they’re up to PBM standards.
- Make Documentation a Habit, Not an Afterthought
- When in doubt, document everything. Solid records don’t just help with audits—they reinforce transparency and accountability in every part of your operation.
- Train and Update Your Team Regularly
- Keep your staff informed and engaged with the latest compliance guidelines. From handling high-cost medications to controlled substances, well-trained staff can make all the difference in staying audit-ready.
- Review Patterns and Adjust as Needed
- Monthly or quarterly reviews help you spot any unusual patterns early on, so you can address issues before PBMs notice them.
- Stay Current on PBM and Regulatory Updates
- Compliance is a moving target. By staying informed and adjusting to new PBM guidelines or regulatory changes, you can keep your pharmacy prepared and avoid last-minute scrambling when audits occur.
Ultimately, preparing for audits isn’t just about avoiding PBM scrutiny; it’s about building a resilient, well-organized pharmacy that serves patients effectively. With a proactive, consistent approach to these common triggers, you can focus on what really matters—providing quality care to your patients, without the stress of constant PBM concerns.
Navigating Informed Consent Requirements in Telehealth: A Provider’s Guide
We examine the complex requirements and risks associated with informed consent for telehealth providers. The article provides actionable advice on navigating the regulatory landscape and practical steps to ensure legal compliance and patient safety.
Read More >>Pennsylvania Board Closes Investigation of HLA Client with No Action
Telemedicine business models may prompt regulatory scrutiny, including board investigations. In this case, HLA's experienced defense attorneys successfully resolved a three-year, multi-state investigation with no licensing or other implications.
Read More >>Department of Justice Declines to Prosecute HLA Client for Alleged $6M Fraud
After the Department of Justice threatened to indict our client for involvement in an alleged $6M healthcare fraud, we stood firm and our tenacious advocacy ultimately convinced the Strike Force to decline prosecution, representing a complete win for HLA's client.
Read More >>Triumph Over Optum: HLA’s Tenacious Advocacy Reverses Optum’s Termination of a Texas Pharmacy
Health Law Alliance successfully reversed Optum’s termination of a Texas pharmacy from its network, protecting the pharmacy from severe financial and reputational damage. Our healthcare attorneys used strategic legal expertise and negotiations to overturn the decision, ensuring the pharmacy could continue serving patients. This victory highlights our dedication to strong advocacy and proven results.
Read More >>